Shoaf, S. E., Bricmont, P., & Mallikaarjun, S. (2012). Effects of CYP3A4 inhibition and induction on the pharmacokinetics and pharmacodynamics of tolvaptan, a non-peptide AVP antagonist in healthy subjects. Blackwell Science Inc.
शिकागो स्टाइल उद्धरणShoaf, Susan E., Patricia Bricmont, और Suresh Mallikaarjun. Effects of CYP3A4 Inhibition and Induction On the Pharmacokinetics and Pharmacodynamics of Tolvaptan, a Non-peptide AVP Antagonist in Healthy Subjects. Blackwell Science Inc, 2012.
एमएलए उद्धरणShoaf, Susan E., Patricia Bricmont, और Suresh Mallikaarjun. Effects of CYP3A4 Inhibition and Induction On the Pharmacokinetics and Pharmacodynamics of Tolvaptan, a Non-peptide AVP Antagonist in Healthy Subjects. Blackwell Science Inc, 2012.
चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.